secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2024-10-15T23:59:59+00:00
Accession:  0001628280-24-042835
Event type: leadership
Sentiment:  negative
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Beauty Health terminates CRO Daniel Watson without cause, effective Oct 14
--------------------------------------------------------------------------

- Daniel Watson terminated as Chief Revenue Officer without cause, effective October 14, 2024.
- Watson will remain as advisor until no later than December 31, 2024.
- Separation agreement pending; amendment to 8-K to be filed within four business days of agreement.
- Termination not related to any disagreement on financial reporting, operations, or policies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828024042835/0001628280-24-042835-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828024042835/skin-20241008.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-042835

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer